110902 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Avulavirus, e.g. Newcastle disease virus; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN IMMUNIZING AGAINST SARS-COV-2 OMICRON VARIANT
#2RECOMBINANT PROTEIN FOR DISPLAYING S PROTEIN OF SARS-COV-2, RECOMBINANT VIRION, AND USE THEREOF
#3RECOMBINANT NEWCASTLE DISEASE VIRUS (rNDV) VECTORS AND METHODS OF USING THE SAME
#4CHIMERIC NEWCASTLE DISEASE VIRUS EXPRESSING APMV HN AND F PROTEINS
#5RECOMBINANT VACCINE AGAINST COVID-19 BASED ON A PARAMYXOVIRUS VIRAL VECTOR
#6RECOMBINANT NEWCASTLE DISEASE VIRUS AND PREPARATION METHOD THEREFOR, RECOMBINANT PLASMID, AND USE THEREOF
#7VEGFR-3-ACTIVATING AGENTS AND ONCOLYTIC VIRUSES AND USES THEREOF FOR THE TREATMENT OF CANCER
#8Oncolytic virus for colorectal cancer treatment using colorectal cancer cell-specific infectious newcastle disease virus and composition for colorectal cancer treatment using same
#9ENGINEERED NEWCASTLE DISEASE VIRUS VECTOR AND USES THEREOF
#10Oncolytic virus for treating brain tumors using recombinant Newcastle disease virus into which Newcastle disease virus vector-based PTEN gene is inserted and composition for treating brain tumors using same
#11Compositions featuring an attenuated newcastle disease virus and methods of use for treating neoplasia
#12Compositions and methods for making and using virus-like particles (VLPs)
#13Newcastle disease viruses and uses thereof
#14Newcastle Disease Viruses and Uses Thereof
#15Newcastle Disease Viruses And Uses Thereof
#16Newcastle disease virus vectored avian vaccines
#17Immunogenic composition
#18Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector
#19Chimeric viruses presenting non-native surface proteins and uses thereof
#20Compositions featuring an attenuated Newcastle disease virus and methods of use for treating neoplasia
#21Chimeric newcastle disease viruses and uses thereof
#22Influenza virus vaccines and uses thereof
#23Newcastle disease virus vectored herpesvirus vaccines
#24RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE
#25Heat-resistant newcastle disease virus live vaccine vector system and use thereof
#26Newcastle disease virus vectored avian vaccines
#27Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same
#28Chimeric Newcastle disease viruses and uses thereof
#29RECOMBINANT MULTIMERIC INFLUENZA PROTEINS
#30USE OF NEWCASTLE DISEASE VIRUS-BASED VECTOR FOR INDUCING AN IMMUNE RESPONSE IN MAMMALS
#31Chimeric viruses presenting non-native surface proteins and uses thereof
#32Recombinant newcastle disease viruses useful as vaccines or vaccine vectors
#33Helper-free Rescue of Recombinant Negative Strand RNA Virus Systems
#34Chimeric Newcastle disease viruses and uses thereof
#35Newcastle disease virus vectored herpesvirus vaccines
#36RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE
#37Recombinant avian paramyxovirus vaccine and method for making and using thereof
#38COMPOSITIONS AND METHODS FOR PREVENTING INFLUENZA INFECTION IN CANINES, FELINES AND EQUINES
#39RECOMBINANT NEWCASTLE DISEASE VIRUS
#40Influenza virus vaccines and uses thereof
#41Newcastle disease virus vectored avian vaccines
#42Attenuated recombinant newcastle disease virus and vaccine containing the same
#43ATTENUATED ONCOLYTIC PARAMYXOVIRUSES ENCODING AVIAN CYTOKINES
#44Recombinant Newcastle Disease Virus Expressing H5 Hemagglutinin of Avian Influenza Virus
#45AVIAN VIRUS VACCINES AND USES THEREOF
#46Recombinant mononegaviral virus vectors
#47Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same
#48Recombinant negative strand RNA virus expression systems and vaccines
#49Recombinant Newcastle Disease Virus
#50Recombinant negative strand virus RNA expression systems and vaccines
#51Vaccine composition for preventing human infection of SARS coronavirus and alleviating infection symptoms